A new licensing agreement with MSCI will expand SGX’s derivatives lineup across developed-market, Asia-Pacific and emerging Asia benchmarks, with about 40 contracts planned in the first phase.
Singapore Exchange said on July 23 that it signed a new licensing agreement with MSCI to expand its derivatives business with up to 100 new futures and options contracts. The planned products will cover global developed-market benchmarks, Asia-Pacific single-country indexes and Emerging Market Asia sector indexes, with roughly 40 contracts expected in the initial phase. SGX CEO Loh Boon Chye said the expansion would help build a comprehensive MSCI suite for managing global equity risks from one venue, while MSCI CEO Henry Fernandez said it would broaden institutional access to MSCI benchmarks. The rollout comes as SGX reported record liquidity in its equity derivatives markets in 2025, reinforcing its push to widen its range of index-based trading and risk-management products.